Related Citations for PubMed (Select 18796139) - PubMed

<< First< Prev

Page of 18

Results: 1 to 20 of 345

Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.

Loibl S, von Minckwitz G, Harbeck N, Janni W, Elling D, Kaufmann M, Eggemann H, Nekljudova V, Sommer H, Kiechle M, Kümmel S.

Breast Cancer Res. 2008;10(5):R77. Epub 2008 Sep 16.

PMID:: 18796139; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.

Kümmel S, Krocker J, Kohls A, Breitbach GP, Morack G, Budner M, Blohmer JU, Lichtenegger W, Elling D.

Crit Rev Oncol Hematol. 2006 May;58(2):166-75. Epub 2006 Jan 18.

PMID:: 16387512; [PubMed - indexed for MEDLINE]

Related citations

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.

Fountzilas G, Dafni U, Gogas H, Linardou H, Kalofonos HP, Briasoulis E, Pectasides D, Samantas E, Bafaloukos D, Stathopoulos GP, Karina M, Papadimitriou C, Skarlos D, Pisanidis N, Papakostas P, Markopoulos C, Tzorakoeleftherakis E, Dimitrakakis K, Makrantonakis P, Xiros N, Polichronis A, Varthalitis I, Karanikiotis C, Dimopoulos AM; Hellenic Cooperative Oncology Group.

Ann Oncol. 2008 May;19(5):853-60. Epub 2007 Nov 27.

PMID:: 18042835; [PubMed - indexed for MEDLINE]

Free Article

Related citations

Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancer.

Schwartz J, Domchek SM, Hwang WT, Fox K.

Ann Oncol. 2005 Feb;16(2):247-52.

PMID:: 15668278; [PubMed - indexed for MEDLINE]

Free Article

Related citations

Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer.

Han HS, Ro J, Lee KS, Nam BH, Seo JA, Lee DH, Lee H, Lee ES, Kang HS, Kim SW.

Breast Cancer Res Treat. 2009 May;115(2):335-42. Epub 2008 May 28.

PMID:: 18506620; [PubMed - indexed for MEDLINE]

Related citations

Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.

Hurria A, Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Howard J, Hudis C.

Drugs Aging. 2005;22(9):785-91.

PMID:: 16156682; [PubMed - indexed for MEDLINE]

Related citations

Phase I/II trial of adjuvant dose-dense docetaxel/epirubicin/cyclophosphamide (TEC) in stage II and III breast cancer.

Burdette-Radoux S, Wood ME, Olin JJ, Laughlin RS, Crocker AM, Ashikaga T, Muss HB.

Breast J. 2007 May-Jun;13(3):274-80.

PMID:: 17461902; [PubMed - indexed for MEDLINE]

Related citations

Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens.

Berger AM, Lockhart K, Agrawal S.

Oncol Nurs Forum. 2009 Sep;36(5):563-70.

PMID:: 19726396; [PubMed - indexed for MEDLINE]

Related citations

[Neoadjuvant treatment for locally advanced breast cancer. Comparison of two schemes based on docetaxel-epirubicin vs. 5-fluorouracil-epirubicin-cyclophosphamide].

Cortés-Flores AO, Morgan-Villela G, Castro-Cervantes JM, Vázquez-Camacho G, Fuentes-Orozco C, González-Ojeda A.

Cir Cir. 2008 Jan-Feb;76(1):23-8. Spanish.

PMID:: 18492416; [PubMed - indexed for MEDLINE]

Related citations

10.

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer.

Fountzilas G, Pectasides D, Christodoulou C, Timotheadou E, Economopoulos T, Papakostas P, Papadimitriou C, Gogas H, Efstratiou I, Skarlos D.

Med Oncol. 2006;23(4):479-88.

PMID:: 17303906; [PubMed - indexed for MEDLINE]

Related citations

11.

Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.

Burstein HJ, Keshaviah A, Baron AD, Hart RD, Lambert-Falls R, Marcom PK, Gelman R, Winer EP.

Cancer. 2007 Sep 1;110(5):965-72.

PMID:: 17614302; [PubMed - indexed for MEDLINE]

Free Article

Related citations

12.

Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.

Muss HB, Berry DA, Cirrincione C, Budman DR, Henderson IC, Citron ML, Norton L, Winer EP, Hudis CA; Cancer and Leukemia Group B Experience.

J Clin Oncol. 2007 Aug 20;25(24):3699-704.

PMID:: 17704418; [PubMed - indexed for MEDLINE]

Related citations

13.

Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.

von Minckwitz G, Kümmel S, Vogel P, Hanusch C, Eidtmann H, Hilfrich J, Gerber B, Huober J, Costa SD, Jackisch C, Loibl S, Mehta K, Kaufmann M; German Breast Group.

J Natl Cancer Inst. 2008 Apr 16;100(8):542-51. Epub 2008 Apr 8.

PMID:: 18398097; [PubMed - indexed for MEDLINE]

Free Article

Related citations

14.

[Feasibility of FEC 100 followed by DOC 100 as adjuvant chemotherapy for breast cancer].

Abe H, Umeda T, Tanaka M, Kawai Y, Mori T, Cho H, Kubota Y, Mekata E, Kurumi Y, Tani T.

Gan To Kagaku Ryoho. 2010 Aug;37(8):1483-7. Japanese.

PMID:: 20716872; [PubMed - indexed for MEDLINE]

Related citations

15.

[Dose dense chemotherapy in the postoperative adjuvant treatment for breast cancer].

Zhou YD, Sun Q, Huan HY, Mao F, Guan JH.

Zhonghua Zhong Liu Za Zhi. 2007 Apr;29(4):316-8. Chinese.

PMID:: 17760265; [PubMed - indexed for MEDLINE]

Related citations

16.

[Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer].

Fattoruso SI, Rossi S, Vici P, Di Filippo F, Botti C, Di Lauro L, Foggi P, Saracca E, Ferranti FR, Visca P, Lopez M.

Clin Ter. 2008 Nov-Dec;159(6):443-7. Review. Italian.

PMID:: 19169606; [PubMed - indexed for MEDLINE]

Related citations

17.

Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.

Michalaki V, Gennatas S, Gennatas K.

Anticancer Drugs. 2009 Mar;20(3):204-7.

PMID:: 19174694; [PubMed - indexed for MEDLINE]

Related citations

18.

Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.

Huober J, von Minckwitz G, Denkert C, Tesch H, Weiss E, Zahm DM, Belau A, Khandan F, Hauschild M, Thomssen C, Högel B, Darb-Esfahani S, Mehta K, Loibl S.

Breast Cancer Res Treat. 2010 Nov;124(1):133-40. Epub 2010 Aug 10.